In the four longitudinal CRC cases, the MT-ND1 content in the plasma of No.3 patient dramatically decreased at the fifth chemotherapy compared to the MT-ND1 content before the operation, which had not been observed in the other three CRC patients (Figure 4B). Here, MT-ND1 is linked to colorectal carcinoma.